atglistatin and Inflammation

atglistatin has been researched along with Inflammation* in 3 studies

Other Studies

3 other study(ies) available for atglistatin and Inflammation

ArticleYear
Pharmacological Upregulation of Microglial Lipid Droplet Alleviates Neuroinflammation and Acute Ischemic Brain Injury.
    Inflammation, 2023, Volume: 46, Issue:5

    Lipid droplets (LDs) were reported to play an important role in the modulation of inflammation and various cellular processes among multiple cell types. However, LDs accumulation, its function and mechanisms of its formation during ischemic stroke remained poorly-identified. In this study, we observed increased LDs accumulation in microglia at the acute stage of ischemic stroke by immunofluorescence and flow cytometry. Transcriptomic analysis indicated that microglia accumulated with LDs were associated with inflammation and phagocytosis. Both inflammatory activation and phagocytosis of tissue debris in microglia could contribute to LDs formation. Moreover, through specific LDs depletion and overload experiments by pharmacological approaches, we proposed that LDs was critical for the maintenance of anti-inflammatory properties of microglia. Furthermore, Atglistatin, a specific adipose triglyceride lipase (ATGL) inhibitor, was shown to prevent proinflammatory cytokines production in primary microglia through decreased LDs lipolysis. After Atglistatin treatment, middle cerebral artery occlusion (MCAO) mice showed decreased infarct volume and improved neurobehavioral performance at the acute stage of stroke. Our findings provided a biological basis for microglial LDs regulation as a potential therapeutic strategy for acute ischemic stroke and uncovered the neuroprotective role of Atglistatin in the treatment of MCAO mice.

    Topics: Animals; Brain Injuries; Brain Ischemia; Infarction, Middle Cerebral Artery; Inflammation; Ischemic Stroke; Lipid Droplets; Mice; Microglia; Neuroinflammatory Diseases; Up-Regulation

2023
The Therapeutic Effects of a PEDF-Derived Short Peptide on Murine Experimental Dry Eye Involves Suppression of MMP-9 and Inflammation.
    Translational vision science & technology, 2022, 10-03, Volume: 11, Issue:10

    To evaluate the efficacy of a pigment epithelium-derived factor (PEDF)-derived short peptide 29-mer, on the treatment and prevention of experimental dry eye (EDE).. C57BL/6 mice were housed in a low humidity controlled environment chamber for 14 days to induce EDE. The 29-mer was administered topically to their eyes, for treatment or dosing, from the point of housing in the controlled environment chamber. The efficacy of the 29-mer on EDE was evaluated in terms of corneal epithelial integrity, tear secretion, and the density of conjunctival goblet cells. PEDF and inflammatory factors, including tumor necrosis factor-α, IL-1β, IL-6, monocyte chemotactic protein (MCP)-1, matrix metalloproteinase-9, and macrophage infiltration, were examined by real-time polymerase chain reaction, Western blotting, and immunostaining. The involvement of the PEDF receptor/PNPLA2 on the 29-mer effects was evaluated by a specific inhibitor, atglistatin. Rabbit corneal epithelial cells were exposed to hyperosmotic medium to induce inflammatory responses.. The levels of PEDF protein increased in the corneal epithelium of EDE, compared with the nonstressed mice. The 29-mer showed a therapeutic effect on EDE and prevented the development of EDE, accompanied by amelioration of the inflammatory factors. The 29-mer effects of inflammatory relief were dramatically reversed by atglistatin. The 29-mer also suppressed the expression of matrix metalloproteinase-9 and proinflammatory cytokines in rabbit corneal epithelial cells induced by hyperosmolarity.. Through this animal study, we provide a proof of concept of the anti-inflammatory domain of PEDF having potential to treat dry eye disease.. This study shows the 29-mer has novel potential as an ophthalmic drop treatment for dry eye disease.

    Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Eye Proteins; Inflammation; Interleukin-6; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Monocyte Chemoattractant Proteins; Nerve Growth Factors; Phenylurea Compounds; Rabbits; Serpins; Tumor Necrosis Factor-alpha

2022
Heterogeneity of chemical composition of lipid droplets in endothelial inflammation and apoptosis.
    Biochimica et biophysica acta. Molecular cell research, 2020, Volume: 1867, Issue:6

    Lipid droplets (LDs) play regulatory role in various cells but their significance in endothelial pathophysiology is still not well understood. Here, we studied LDs in in situ endothelial cells (ECs) in isolated blood vessels stimulated with pro-inflammatory or pro-apoptotic stimuli using Raman and fluorescence imaging. Endothelial inflammation induced by murine TNF-α (mTNF-α) was featured by overexpression of ICAM-1, vWF, increased production of PGI

    Topics: Animals; Cells, Cultured; Endothelial Cells; Fas Ligand Protein; Humans; Inflammation; Intercellular Adhesion Molecule-1; Lipid Droplets; Mice; Phenylurea Compounds; Prostaglandins I; Spectrum Analysis, Raman; Tumor Necrosis Factor-alpha; von Willebrand Factor

2020